Pyoverdine and proteases affect the response of pseudomonas aeruginosa to gallium in human serum

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 9, 2015, Pages 5641-5646

  Bonchi, Carlo ^a   Frangipani, Emanuela ^a   Imperi, Francesco ^b   Visca, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASAMINO ACID; GALLIUM NITRATE; IRON; IRON BINDING PROTEIN; PLASMA PROTEIN; PROTEINASE; PYOVERDINE; ANTIINFECTIVE AGENT; GALLIUM; OLIGOPEPTIDE; PEPTIDE HYDROLASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CYSTIC FIBROSIS; DRUG EFFICACY; GROWTH INHIBITION; IRON RESTRICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SERUM; BLOOD; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; GALLIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PEPTIDE HYDROLASES; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

EID: 84940936646     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01097-15     Document Type: Article

References (44)

1. Weinberg ED. 2009. Iron availability and infection. Biochim Biophys Acta 1790:600-605. http://dx.doi.org/10.1016/j.bbagen.2008.07.002.
2. Faraldo-Gómez JD, Sansom MS. 2003. Acquisition of siderophores in gram-negative bacteria. Nat Rev Mol Cell Biol 4:105-116. http://dx.doi .org/10.1038/nrm1015.
3. Wandersman C, Delepelaire P. 2004. Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 58:611-647. http://dx.doi .org/10.1146/annurev.micro.58.030603.123811.
4. Döring G, Pfestorf M, Botzenhart K, Abdallah MA. 1988. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin. Infect Immun 56:291-293.
5. Foley TL, Simeonov A. 2012. Targeting iron assimilation to develop new antibacterials. Expert Opin Drug Discov 7:831-847. http://dx.doi.org/10 .1517/17460441.2012.708335.
6. Imperi F, Massai F, Facchini M, Frangipani E, Visaggio D, Leoni L, Bragonzi A, Visca P. 2013. Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proc Natl Acad Sci U S A 110:7458-7463. http://dx.doi.org/10.1073/pnas.1222706110.
7. Bernstein LR. 1998. Mechanisms of therapeutic activity for gallium. Pharmacol Rev 50:665-682.
8. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. 2007. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117:877-888. http://dx.doi.org/10.1172/JCI30783.
9. Banin E, Lozinski A, Brady KM, Berenshtein E, Butterfield PW, Moshe M, Chevion M, Greenberg EP, Banin E. 2008. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci USA105:16761-16766. http://dx.doi.org/10.1073 /pnas.0808608105.
10. DeLeon K, Balldin F, Watters C, Hamood A, Griswold J, Sreedharan S, Rumbaugh KP. 2009. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob Agents Chemother 53:1331-1337. http://dx.doi.org/10.1128/AAC.01330-08.
11. Minandri F, Bonchi C, Frangipani E, Imperi F, Visca P. 2014. Promises and failures of gallium as an antibacterial agent. Future Microbiol 9:379-397. http://dx.doi.org/10.2217/fmb.14.3.
12. Rangel-Vega A, Bernstein LR, Mandujano-Tinoco EA, García-Contreras SJ, García-Contreras R. 2015. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. Front Microbiol 6:282. http://dx.doi.org/10.3389/fmicb.2015.00282.
13. Goss CH, Hornick DB, Aitken ML, Caldwell E, Wilhelm E, Wolfstone A, Teresi M, Singh PK. 2012. Phase 1 pharmacokinetic and safety study of intravenous GaniteTM (gallium nitrate) in CF. Pediatric Pulmunol 47(Suppl 35):303.
14. Bonchi C, Imperi F, Minandri F, Visca P, Frangipani E. 2014. Repurposing of gallium-based drugs for antibacterial therapy. Biofactors 40: 303-312. http://dx.doi.org/10.1002/biof.1159.
15. Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. 2010. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother 54:3717-3722. http: //dx.doi.org/10.1128/AAC.00207-10.
16. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM.1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 30:1899-1902.
17. Visca P, Ciervo A, Sanfilippo V, Orsi N. 1993. Iron-regulated salicylate synthesis by Pseudomonas spp. J Gen Microbiol 139:1995-2001. http://dx .doi.org/10.1099/00221287-139-9-1995.
18. Antunes LC, Imperi F, Minandri F, Visca P. 2012. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 56:5961-5970. http://dx.doi.org/10.1128/AAC.01519-12.
19. Imperi F, Tiburzi F, Visca P. 2009. Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad SciUSA 106:20440-20445. http://dx.doi.org/10.1073/pnas.0908760106.
20. Meyer JM, Stintzi A, De Vos D, Cornelis P, Tappe R, Taraz K, Budzikiewicz H. 1997. Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143:35-43. http://dx.doi.org/10.1099/00221287-143-1-35.
21. James HE, Beare PA, Martin LW, Lamont IL. 2005. Mutational analysis of a bifunctional ferrisiderophore receptor and signal-transducing protein from Pseudomonas aeruginosa. J Bacteriol 187:4514-4520. http://dx.doi .org/10.1128/JB.187.13.4514-4520.2005.
22. th informational supplement, M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Haag M, Meyer HE, Schollmeyer P, Hörl WH. 1987. Characterization of non-TCA-precipitable 'Lowry protein' in plasma of patients with acute renal failure. Clin Chim Acta 170:181-186. http://dx.doi.org/10.1016 /0009-8981(87)90126-4.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
25. Putignani L, Ambrosi C, Ascenzi P, Visca P. 2004. Expression of L-ornithine Ndelta-oxygenase (PvdA) in fluorescent Pseudomonas species: an immunochemical and in silico study. Biochem Biophys Res Commun 313:245-257. http://dx.doi.org/10.1016/j.bbrc.2003.11.116.
26. Duan K, Surette MG. 2007. Environmental regulation of Pseudomonas aeruginosa PAO1 Las and Rhl quorum-sensing systems. J Bacteriol 189: 4827-4836. http://dx.doi.org/10.1128/JB.00043-07.
27. Massai F, Imperi F, Quattrucci S, Zennaro E, Visca P, Leoni L. 2011. A multitask biosensor for micro-volumetric detection of N-3-oxododecanoyl-homoserine lactone quorum sensing signal. Biosens Bioelectron 26:3444-3449. http://dx.doi.org/10.1016/j.bios.2011.01.022.
28. Ankenbauer R, Sriyosachati S, Cox CD. 1985. Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun 49:132-140.
29. Visca P, Ciervo A, Orsi N. 1994. Cloning and nucleotide sequence of the pvdA gene encoding the pyoverdin biosynthetic enzyme L-ornithine N5 -oxygenase in Pseudomonas aeruginosa. J Bacteriol 176:1128-1140.
30. Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 24:260-264.
31. th Int Conf Pseudomonas, abstr 167.
32. Imperi F, Putignani L, Tiburzi F, Ambrosi C, Cipollone R, Ascenzi P, Visca P. 2008. Membrane-association determinants of the omega-amino acid monooxygenase PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa. Microbiology 154:2804-2813. http://dx.doi.org/10 .1099/mic.0.2008/018804-0.
33. Frangipani E, Bonchi C, Minandri F, Imperi F, Visca P. 2014. Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. Antimicrob Agents Chemother 58:5572-5575. http://dx.doi.org/10.1128 /AAC.03154-14.
34. Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F. 2013. The dual personality of iron chelators: growth inhibitors or promoters? Antimicrob Agents Chemother 57:2432-2433. http://dx.doi.org/10 .1128/AAC.02529-12.
35. Jimenez PN, Koch G, Thompson JA, Xavier KB, Cool RH, Quax WJ. 2012. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 76:46-65. http://dx.doi.org/10.1128 /MMBR.05007-11.
36. Pessi G, Haas D. 2000. Transcriptional control of the hydrogen cyanide biosynthetic genes hcnABC by the anaerobic regulator ANR and the quorumsensing regulators LasR and RhlR in Pseudomonas aeruginosa. J Bacteriol 182:6940-6949. http://dx.doi.org/10.1128/JB.182.24.6940-6949.2000.
37. Cowell BA, Twining SS, Hobden JA, Kwong MS, Fleiszig SM. 2003. Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology 143:2291-2299.
38. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D, Olson MV, Manoil C. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 14339-14344. http://dx.doi.org/10.1073/pnas.2036282100.
39. Wilderman PJ, Vasil AI, Johnson Z, Wilson MJ, Cunliffe HE, Lamont IL, Vasil ML. 2001. Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun 69: 5385-5394. http://dx.doi.org/10.1128/IAI.69.9.5385-5394.2001.
40. Girardello R, Bispo PJ, Yamanaka TM, Gales AC. 2012. Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol 50:2414-2418. http: //dx.doi.org/10.1128/JCM.06686-11.
41. Antunes LC, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674. http://dx.doi.org/10.1371/journal.pone.0022674.
42. de Léséleuc L, Harris G, KuoLee R, Chen W. 2012. In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob Agents Chemother 56:5397-5400. http: //dx.doi.org/10.1128/AAC.00778-12.
43. Collery P, Keppler B, Madoulet C, Desoize B. 2002. Gallium in cancer treatment. Crit Rev Oncol Hematol 42:283-296. http://dx.doi.org/10 .1016/S1040-8428(01)00225-6.
44. Kurioka S, Liu PV. 1967. Effect of the hemolysin of Pseudomonas aeruginosa on phosphatides and on phospholipase c activity. J Bacteriol 93:670-674.